Related Experiment Video

Updated: May 25, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Restrictive pulmonary dysfunction and its predictors in young patients with β-thalassaemia major

Evangelia Bourli1, Meropi Dimitriadou, Marina Economou

  • 1First Paediatric Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Pediatric Pulmonology
|February 14, 2012
PubMed

Insights

Pulmonary dysfunction is common in young patients with beta-thalassaemia major, even when asymptomatic. Regular pulmonary function screening is recommended for early detection and management of lung impairment.

Area of Science:

  • Hematology
  • Pulmonology
  • Pediatrics

Background:

  • Pulmonary dysfunction is an underrecognized complication in beta-thalassaemia.
  • This condition can significantly impact patient health and quality of life.

Purpose of the Study:

  • To assess pulmonary dysfunction patterns in young beta-thalassaemia major patients.
  • To identify factors associated with lung impairment in this population.

Main Methods:

  • Studied 52 young patients with beta-thalassaemia major undergoing standard treatment.
  • Utilized computerized pulmonary function testing (PFT) to evaluate lung capacity and diffusion.

Main Results:

  • 38.46% of patients exhibited a restrictive pulmonary pattern, more common in older, shorter individuals.
  • Lower diffusing capacity for carbon monoxide (DLCO) was noted in the restrictive group.
  • Age and serum ferritin levels were identified as key predictors of restrictive pulmonopathy.

Conclusions:

  • Pulmonary impairment affects a significant proportion of young, asymptomatic beta-thalassaemia patients.
  • Routine pulmonary function screening is crucial for early detection and management in clinical follow-up.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.